Formamide

Formamide

SCHEMBL29133744

Cc1cc(-c2ccc3ncnc(NCCc4ccccc4)c3c2)cnc1C.NC=O

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 9/20 0.51
LMNA P02545 6/20 0.51
EGFR P00533 3/20 0.51
APP P05067 1/20 0.51
HTT P42858 1/20 0.51
CCNC P24863 1/20 0.51
CDKN1A P38936 1/20 0.51
CDK8 P49336 1/20 0.51
CDK19 Q9BWU1 1/20 0.51
DYRK1A Q13627 1/20 0.51
FYN P06241 1/20 0.50
SRC P12931 1/20 0.50
CNR1 P21554 1/20 0.48
CNR2 P34972 1/20 0.48
PIK3CA P42336 1/20 0.47
ALDH1A1 P00352 8/20 0.47
CYP3A4 P08684 8/20 0.47
CYP2D6 P10635 8/20 0.47
CYP2C19 P33261 8/20 0.47
HSD17B10 Q99714 8/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29133712 0.86 MAPK1 (0.55) MAPK1LMNAEGFRAPPHTT
SCHEMBL29133751 0.82 EGFR (0.68) MAPK1LMNAEGFRAPPHTT
SCHEMBL29133765 0.80 EGFR (0.54) MAPK1LMNAEGFRAPPHTT
SCHEMBL29133726 0.80 MAPK1 (0.61) MAPK1LMNAEGFRAPPHTT
Formamide SCHEMBL27170402 0.80 EGFR (0.61) LMNAEGFRDYRK1APIK3CA
SCHEMBL29133772 0.78 CYP1A2 (0.57) MAPK1LMNAEGFRAPPHTT
SCHEMBL29133727 0.77 PIK3CA (0.65) MAPK1LMNAEGFRAPPHTT
SCHEMBL29133760 0.76 DYRK1A (0.52) MAPK1LMNAEGFRAPPHTT
SCHEMBL29133700 0.76 DYRK1A (0.56) MAPK1LMNAEGFRAPPHTT
SCHEMBL29133714 0.76 SLC29A1 (0.60) MAPK1LMNAEGFRAPPHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117295716-A Substituted aminobenzyl heteroaryl compounds as EGFR and/or PI3K inhibitors 麦克尼斯迪克治疗有限公司 2023-12-26 CN disclosed